IRVINE, Calif., Aug. 24, 2011 /PRNewswire/ — Masimo
(NASDAQ:
MASI) announced today that it has received CE Mark for its
SEDLine brain function monitor — expanding access to
and availability of SEDLine’s advanced neuromonitoring technology
to hospitals and clinicians across Europe. The only brain
function monitor with four separate EEG channels in a single
integrated algorithm SEDLine represents a critical advancement for
the practice of anesthesia in Europe — more complete data for
a more complete picture of brain function and sedation.
SEDLine expands the scope of real-time data and improves the
management of an anesthetic case by enabling more individualized
titration. Four channels of high-quality EEG data provide
information about both sides of the brain to facilitate immediate
detection of asymmetrical activity and yields a single
sophisticated algorithm to give accurate, reliable information
about a patient’s response to anesthesia. Masimo’s SEDLine
Patient State Index (PSI™), a calculated measure of brain
activity that reflects the patient’s current level of
sedation/anesthesia(1), provides additional data to enhance
anesthetic control and facilitate rapid assessment. With
demonstrated reliability under challenging clinical conditions and
superior resistance to cautery(2), SEDLine offers a cost-effective
solution for brain function monitoring that helps clinicians
achieve targeted sedation throughout all phases of anesthesia
— in the OR and ICU.
(Photo: http://photos.prnewswire.com/prnh/20110824/LA55746)
According to Michael Ramsay, M.D., Chief of Anesthesiology and
Pain Management & President of the Research Institute at Baylor
University Medical Center in Dallas, Texas
‘/>”/>
